Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study
Completed · Phase 2 · Has a placebo group
Conditions studied: Brain Injuries, Wounds and Injuries, Hemorrhage
In brief
Trauma is the leading cause of death and disability in children in the United States. The long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children. This is a 40-patient pilot study to evaluate the feasibility of two subsequent large-scale studies of TXA in injured children.
Key facts
- Study ID
- NCT02840097
- Run by
- Daniel Nishijima, MD, MAS
- People needed
- 31
- Starts
- 2019-03-04
- Expected to finish
- 2020-10-03
- Last updated by the study team
- 2021-09-05
Who can join
Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Less than 18 years old AND
- Penetrating torso trauma, blunt torso trauma, or head trauma as defined below.
- Penetrating Torso Trauma:
- a. Penetrating trauma to the chest, abdomen, neck, pelvis or thigh with at least one of the following:
- age-adjusted hypotension, or
- age-adjusted tachycardia despite adequate resuscitation fluids, or
- radiographic evidence of internal hemorrhage, or
- clinician suspicion of ongoing internal hemorrhage
- Blunt Torso Trauma (at least one of the following):
- Clinician suspicion of hemorrhagic blunt torso injury and at least one of the following:
- age-adjusted hypotension, or
- persistent age-adjusted tachycardia despite adequate resuscitation fluids
- Hemothorax on chest tube placement or imaging,
- Clinical suspicion of hemorrhagic blunt torso injury and Intraperitoneal fluid on abdominal ultrasonography (Focused Assessment with Sonography in Trauma),
- Intra-abdominal injury on CT with either contrast extravasation or more than trace intraperitoneal fluid,
- Pelvic fracture with contrast extravasation or hematoma on abdominal/pelvic CT scan with at least one of the following:
- Age-adjusted tachycardia, or
- Age-adjusted hypotension.
- Head Trauma:
- Initial Glasgow Coma Scale (GCS) score 3 to 13 with associated intracranial hemorrhage on cranial CT scan (enroll after cranial CT scan)
You may not qualify if…
- Unable to administer study drug within 3 hours of traumatic event
- Known pregnancy
- Known prisoners
- Known wards of the state
- Cardiac arrest prior to randomization
- GCS score of 3 with bilateral unresponsive pupils
- Isolated subarachnoid hemorrhage, epidural hematoma, or diffuse axonal injury
- Known bleeding/clotting disorders
- Known seizure disorders
- Known history of severe renal impairment
- Unknown time of injury
- Previous enrollment into the TIC-TOC trial
- Prior TXA for current injury
- Non-English and non-Spanish speaking
- Known venous or arterial thrombosis
Where it is running
- University of California, Davis — Sacramento, California, United States
- Nationwide Children's Hospital — Columbus, Ohio, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Primary Children's Hospital — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.